Search the Newsreel

Twist Bioscience Corp 2026: Revenue $118.38M, EPS ($0.56) — 10-Q Summary

Twist Bioscience Corp reported its 2026 quarterly results, showing a 23.2% increase in revenue to $118.38M compared to the prior year, driven by growth in DNA synthesis, protein products, and NGS applications. Despite increased revenue, the company's net loss widened to ($35.05M) with a …

TWIST BIOSCIENCE CORP : LEERINK PARTNERS RAISES TARGET PRICE $120.00 FROM $110.00

Leerink Partners has raised its target price for Twist Bioscience Corp (TWST.O) from $110.00 to $120.00. This indicates an increased positive outlook from the analytical firm regarding the company's future stock performance.

Twist Bioscience Jumps as Raised 2026 Outlook Appears to Drive Buying

Twist Bioscience (TWST) stock jumped 10.4% following its fiscal third-quarter update, which included a raised full-year 2026 revenue outlook and continued progress toward adjusted EBITDA breakeven. The company increased its revenue guidance to $456 million-$457 million and highlighted improving execution in its synthetic biology …

Twist Bioscience (TWST) insider Paula Green files to sell 1,133 shares

Twist Bioscience insider Paula Green has filed a Form 144 to sell 1,133 shares of common stock through Fidelity Brokerage Services LLC on August 3, 2026. These shares are linked to restricted stock vesting on July 31, 2026, as compensation. The filing also details …

Twist Bioscience Reports 12.0% Wider Q3 2026 Loss at -$0.56/Share

Twist Bioscience (NASDAQ:TWST) reported a wider-than-expected Q3 2026 diluted loss of $0.56 per share, missing analyst estimates despite achieving robust revenue growth of 23.3% to $118.4 million. The company's net loss reached $35.1 million due to continued investments in capacity expansion and market penetration. …

Twist Bioscience stock falls 5% on earnings miss despite revenue beat

Twist Bioscience Corporation (NASDAQ:TWST) reported third-quarter fiscal 2026 results with a miss on earnings per share but a beat on revenue expectations, leading to a 4.97% drop in pre-market trading. The company achieved a record revenue of $118.4 million, marking its 14th consecutive quarter …

Press Release: Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

Twist Bioscience has announced its financial results for the third quarter of fiscal year 2026. The company reported significant revenue growth and provided updates on its operational progress and future outlook. Key highlights include strong performance across its various product lines and strategic advancements …

Twist Bioscience Shares Decline Following Quarterly Earnings Miss

Twist Bioscience (NASDAQ:TWST) Posts Earnings Results, Misses Estimates By $0.07 EPS

Twist Bioscience (NASDAQ:TWST) Shares Gap Down on Disappointing Earnings

Twist Bioscience (TWST) Earnings Date and Reports 2026 $TWST

Twist Bioscience (TWST) Reports Q3 Loss, Beats Revenue Estimates

Empowered Funds LLC Has $5.34 Million Position in Titan International, Inc. $TWI

Empowered Funds LLC significantly increased its stake in Titan International, Inc. by 27.8% in the first quarter, now holding 773,501 shares valued at $5.34 million. This move is part of broader institutional investment, with various funds either boosting or initiating positions in the company, …

Should Twist Bioscience’s US$17.05 Million Class Action Settlement Reshape Risk Perceptions for TWST Investors?

Twist Bioscience (TWST) recently held a hearing for a proposed US$17.05 million cash settlement to resolve a securities class action lawsuit. This settlement, if approved, would address past legal risks related to capital-raising activities for the period between December 2018 and November 2022. While …

Twist Bioscience Reports Monday With Breakeven Timeline Now Three Quarters Away

Twist Bioscience (TWST) is set to report fiscal third-quarter earnings, with investors focusing on the company's path to profitability and its role in AI-enabled drug discovery after a significant 154% surge in its stock price over the past year. Analysts have a largely bullish …

Titan International (TWI) Stock Faces Margin Squeeze Despite Stronger Cash Flow

Titan International (TWI) experienced a margin squeeze in its core agricultural business during Q2 2026, with agricultural gross margin falling despite overall revenue growth. While the company achieved positive net income and reduced net debt, concerns remain about its dependence on the weakening agricultural …

Twilio Inc. Revenue Breakdown – NYSE:TWLO

Twilio, Inc. Class A Revenue Breakdown – BX:TWH

This article provides a revenue breakdown for Twilio, Inc. Class A (TWH) on the BX Swiss exchange. It highlights that the company generated 4.02 billion CHF last year, with Messaging being the top-performing segment contributing 2.28 billion CHF. The United States was the largest …

Twist Bioscience earnings loom as profitability path under scrutiny

Twist Bioscience Corp. is preparing to report its fiscal third-quarter results, with analysts expecting a loss of 49 cents per share on revenue of $114.6 million, indicating sequential improvement and significant year-over-year growth. The company's stock has rallied 154% over the past year, driven …

TWIN Q4'26 Earnings: revenue estimate is 100.35M USD

Titan International: Q2 Earnings Snapshot

This article provides a snapshot of Titan International's Q2 earnings. Without further information, it's impossible to detail specific financial results, but the title indicates it focuses on the company's performance during that quarter.

Twist Bioscience Number of Employees 2026 | Employee Count & Headcount Data

Twist Bioscience Corp. (TWST) had approximately 1,065 employees worldwide as of March 2026, representing a 5.0% growth from 2023. The company is actively hiring, with 133 job postings in 2026, and its workforce is concentrated in the United States, with a growing presence in …

BlackRock (NYSE: BLK) discloses 5.1% beneficial ownership in Twin Disc (TWIN)

BlackRock, Inc. has disclosed a 5.1% beneficial ownership stake in Twin Disc Inc. (TWIN), totaling 741,659 shares of common stock. This filing, a Schedule 13G, indicates that BlackRock has sole voting power over 733,933 shares and sole dispositive power over all 741,659 shares. The …

TITAN INTERNATIONAL INC 2Q 2026: Revenue $484.77M, EPS $0.09— 10-Q Summary

Titan International Inc. reported strong second-quarter 2026 results, with revenue increasing by 5.2% to $484.77 million and diluted EPS significantly improving to $0.09 from a loss of ($0.07) in the prior year. The company returned to a net income of $5.76 million, driven by …

Twilio stock may move 14% on Aug. 6 earnings release

MarketWise (MKTW) Expected to Post Quarterly Earnings on Thursday

Titan International’s (NYSE:TWI) Q2 CY2026 Sales Beat Estimates But Quarterly Revenue Guidance Misses Expectations

Titan International Inc (TWI) Institutional Confidence

Titan International Inc's institutional shareholding score is 10.00, placing it first in the Automobiles & Auto Parts industry. The company's institutional shareholding proportion increased by 1.28% quarter-over-quarter, reaching 91.41%. Donald G. Smith is the largest institutional shareholder, holding 7.68% of shares outstanding.

Titan International Number of Employees 2026 | Employee Count & Headcount Data

Titan International, Inc. (TWI) had approximately 8,213 total employees worldwide as of March 2026, representing a 3.7% decline from 2023. Despite this, the company is actively hiring, with 105 active job postings in 2026, a 37.3% increase from 2025. The workforce is concentrated in …

Twin Disc Inc (TWIN) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Twin Disc Inc (TWIN), noting its current valuation score of 9.36 and ranking within its industry. It highlights the company's P/E ratio relative to its historical highs and lows, while also stating that P/B, P/S, and P/CF …

Twist Bioscience Market Sentiment

This article provides an overview of market sentiment for Twist Bioscience (TWST), detailing analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" analyst consensus, a 25.7% declining short float, and a bullish options flow with a 0.52 Put/Call ratio, despite …

Titan International, Inc. Revenue Breakdown – BX:TZ4

This article details Titan International, Inc.'s revenue breakdown for the last fiscal year. The company generated CHF 1.45 billion, with the Agricultural segment being the top performer at CHF 587.39 million. The United States was the largest geographical contributor, accounting for CHF 726.22 million …

TWST|Twist Bioscience Corp|Price:85.490|Chg%:-3.060

Twist Bioscience Corp (TWST) shows relatively healthy fundamentals and high growth potential, with its valuation considered fairly valued. Analysts rate it as a Strong Buy with a target price of $94.33. Despite recent weak market performance, the stock is expected to trend upwards in …

TWLO|Twilio Inc|Price:194.380|Chg%:+2.920

Twilio Inc. (TWLO) shows strong fundamentals and high growth potential, with its stock considered fairly valued by TradingKey. Analysts have rated it a "Buy" with a target price of $212.60, indicating an 11.04% upside. The company specializes in customer engagement platforms, offering communication APIs …

Twilio (TWLO) Outperforms Broader Market: What You Need to Know

In the latest close session, Twilio (TWLO) was up +1.57% at $194.47. This move outpaced the S&P 500's daily gain of 0.02%. On the other hand, the Dow registered a gain of 0.51%, and the technology-centric Nasdaq decreased by 0.18%. Heading into today, shares …

Twist Bioscience Corp (TWST) executive sells 2,238 shares in tax sell-to-cover

Twist Bioscience Corp's President and COO, Patrick John Finn, sold 2,238 shares of common stock on July 23, 2026, at $93.893 per share. This sale was a non-discretionary "sell to cover" transaction to meet tax withholding obligations related to the vesting of Restricted Stock …